Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects - Upreti, Vijay V.; Keung, Chi-Fung; Boulton, David W.; Chang, Ming; Li, Li; Tang, Angela; Hsiang, Bonnie C.; Quamina-Edghill, Donette; Frevert, Ernst U.; LaCreta, Frank P. (Clinical drug investigation, 2013)
Keywords: Adamantane - administration & dosage; Adamantane - analogs & derivatives; Adamantane - blood; Adamantane - pharmacokinetics; Administration, Oral; Adult; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Dipeptides - administration & dosage; Dipeptides - blood; Dipeptides - pharmacokinetics; Dipeptidyl-Peptidase IV Inhibitors - administration & dosage; Dipeptidyl-Peptidase IV Inhibitors - blood; Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics; Drug Combinations; Drug Therapy, Combination; Fasting - blood; Female; Humans; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - blood; Hypoglycemic Agents - pharmacokinetics; Internal Medicine; Male; Medicine; Medicine & Public Health; Metformin - administration & dosage; Metformin - blood; Metformin - pharmacokinetics; New Jersey; Original Research Article; Pharmacology/Toxicology; Pharmacotherapy; Postprandial Period; Tablets; Therapeutic Equivalency; Young Adult; New Jersey; Immediate Release; Study Drug Administration; Metformin; Bioequivalence Study; Saxagliptin